NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ ...

Key Players to WatchDublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell Market by Technology Type (CTC Analysis, CTC Detection & Isolation), Product Type (Instruments, Kits & ...

Antibiotic resistance is a growing threat. Empa's innovative sensors offer rapid detection of resistant pathogens, improving ...

A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the ...

Learn about the $12.2 billion contract awarded to the Massachusetts Institute of Technology to operate the federally-funded Lincoln Laboratory R&D center.

As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the ...

Lowenthal & Abrams expands medical malpractice advocacy in Pittsburgh and Western PA, fighting for victims of misdiagnosis ...

We believe Adicon has a manageable financial situation. As of December 2024, it has CNY 768 million cash in hand and a total debt of CNY 1.0 billion. Its debt/capital ratio was 42.4% by the end of ...

Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...

Next-Generation Sequencing and POC Testing Transform IVD Accuracy and SpeedDublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "In-Vitro Diagnostic Market - North America and Country Analysis: Focus on ...